The Role of renal macrophages in recovery from renal injury

肾巨噬细胞在肾损伤恢复中的作用

基本信息

  • 批准号:
    9765295
  • 负责人:
  • 金额:
    $ 59.04万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-05 至 2022-06-30
  • 项目状态:
    已结题

项目摘要

Acute kidney injury (AKI) varies from 5% in all hospitalized patients to 30–50% in intensive care units. The proximate cause of the injury appears to be multifactorial, whether the etiology of AKI is ischemic, septic, toxic or some combination of the three. However, there is increasing evidence for an important role in AKI for both resident and infiltrating macrophages to initiate and exacerbate renal injury by polarization to a pro- inflammatory or “classically activated” (“M1”) phenotype. An unanswered question is: What are the triggers to activate quiescent resident macrophages and monocytes to an M1 phenotype following an episode of AKI? Studies by us and others have also recently demonstrated important roles for tissue reparative or “alternatively activated” (“M2”) macrophages in the recovery from AKI. M2 macrophages are phagocytes and play an important role in the phagocytosis of apoptotic epithelial cells as well as apoptotic neutrophils (“efferocytosis”). There is evidence that when apoptotic cells are not phagocytized, they may eventually rupture and release their cellular contents, a process known as “secondary necrosis”, and these cellular contents may activate viable epithelial cells and infiltrating cells through Fc receptors and toll like receptors (TLRs) and induce inflammatory cytokines. We propose that the failure of renal macrophages to effectively perform these functions is an important factor mediating development of continued inflammation and ineffective repair, which can lead to development of chronic renal insufficiency and we will address: How do M2 macrophages/dendritic cells promote renal epithelial cell repair following AKI? Alterations in metabolism play an important role in polarization of macrophages. M1 macrophages utilize predominantly glucose and glutamine as metabolic substrates, have increased aerobic (“Warburg”) glycolysis and exhibit defects in the Krebs cycle such that there is increased isocitrate, succinate and arginine production. Still unexplored is: What is the role of alterations in immunometabolism in acute kidney injury? There is also increasing evidence that apparent functional recovery from episodes of AKI can be incomplete, even if BUN and serum creatinine levels return toward normal, and the post-AKI kidney is at increased risk both for further injury and for the development of CKD. We will determine if activated, profibrotic renal M2 macrophages play a key role in development of fibrosis in the later stages of recovery from AKI? To answer these questions, we propose three specific aims: Aim 1 Determine the Mechanisms Underlying Development and Action of Proinflammatory Macrophages in Acute Kidney Injury Aim 2 Determine the Role of Immunometabolism in Acute Kidney Injury Aim 3 Determine Mechanisms Mediating Macrophage Promotion of Post-AKI Tubulointerstitial Fibrosis !
急性肾损伤 (AKI) 的发生率从所有住院患者的 5% 到重症监护病房的 30-50% 不等。 损伤的直接原因似乎是多因素的,AKI 的病因是否是缺血性、脓毒症、 然而,越来越多的证据表明,AKI 中具有重要作用。 常驻巨噬细胞和浸润巨噬细胞均通过极化为亲巨噬细胞来引发和加重肾损伤 炎症或“经典激活”(“M1”)表型的一个尚未解答的问题是:触发因素是什么。 AKI 发作后将静止的巨噬细胞和单核细胞激活至 M1 表型? 我们和其他人的研究最近也证明了组织修复或“替代疗法”的重要作用 AKI 恢复过程中“激活的”(“M2”)巨噬细胞 M2 巨噬细胞是吞噬细胞,发挥着重要作用。 在凋亡上皮细胞和凋亡中性粒细胞的吞噬作用中发挥重要作用 (“胞吞作用”)有证据表明,当凋亡细胞不被吞噬时,它们最终可能会被吞噬。 破裂并释放其细胞内容物,这一过程称为“继发性坏死”,并且这些细胞 内容物可能通过 Fc 受体和 toll 样激活活的上皮细胞和浸润细胞 受体(TLR)并诱导炎症细胞因子,我们认为肾功能衰竭。 巨噬细胞有效地执行这些功能是介导发育的重要因素 持续的炎症和无效的修复,可能导致慢性肾病的发展 不足,我们将解决:M2巨噬细胞/树突状细胞如何促进肾上皮细胞 AKI 后的细胞修复?代谢的改变在巨噬细胞的极化中发挥重要作用。 M1巨噬细胞主要利用葡萄糖和谷氨酰胺作为代谢底物,增加了有氧运动 (“Warburg”)糖酵解并在克雷布斯循环中表现出缺陷,导致异柠檬酸、琥珀酸增加 尚未探索的是:免疫代谢的改变在急性发作中的作用是什么。 肾损伤?还有越来越多的证据表明 AKI 发作后的明显功能恢复可以 即使 BUN 和血清肌酐水平恢复正常,并且 AKI 后肾脏处于 进一步损伤和发展为 CKD 的风险增加。我们将确定是否激活、促纤维化。 肾脏 M2 巨噬细胞在 AKI 恢复后期的纤维化发展中发挥关键作用? 回答这些问题,我们提出三个具体目标: 目标 1 确定促炎巨噬细胞发育和作用的潜在机制 急性肾损伤 目标 2 确定免疫代谢在急性肾损伤中的作用 目标 3 确定介导巨噬细胞促进 AKI 后肾小管间质纤维化的机制 !

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RAYMOND C. HARRIS其他文献

RAYMOND C. HARRIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RAYMOND C. HARRIS', 18)}}的其他基金

Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
克隆造血对肾脏疾病进展的影响
  • 批准号:
    10611485
  • 财政年份:
    2022
  • 资助金额:
    $ 59.04万
  • 项目类别:
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
克隆造血对肾脏疾病进展的影响
  • 批准号:
    10419907
  • 财政年份:
    2022
  • 资助金额:
    $ 59.04万
  • 项目类别:
Organ Specific Project - Kidney
器官特定项目 - 肾脏
  • 批准号:
    10201589
  • 财政年份:
    2018
  • 资助金额:
    $ 59.04万
  • 项目类别:
Vanderbilt O'Brien Kidney Center
范德比尔特奥布莱恩肾脏中心
  • 批准号:
    10163162
  • 财政年份:
    2017
  • 资助金额:
    $ 59.04万
  • 项目类别:
Vanderbilt O'Brien Kidney Center-Administrative Core
范德比尔特奥布莱恩肾脏中心-行政核心
  • 批准号:
    10163163
  • 财政年份:
    2017
  • 资助金额:
    $ 59.04万
  • 项目类别:
The Role of renal macrophages in recovery from renal injury
肾巨噬细胞在肾损伤恢复中的作用
  • 批准号:
    10194467
  • 财政年份:
    2013
  • 资助金额:
    $ 59.04万
  • 项目类别:
Role of Renal Macrophages in Recovery from Acute Kidney Injury
肾巨噬细胞在急性肾损伤恢复中的作用
  • 批准号:
    8504287
  • 财政年份:
    2013
  • 资助金额:
    $ 59.04万
  • 项目类别:
Role of Renal Macrophages in Recovery from Acute Kidney Injury
肾巨噬细胞在急性肾损伤恢复中的作用
  • 批准号:
    8713987
  • 财政年份:
    2013
  • 资助金额:
    $ 59.04万
  • 项目类别:
Role of Renal Macrophages in Recovery from Acute Kidney Injury
肾巨噬细胞在急性肾损伤恢复中的作用
  • 批准号:
    9284449
  • 财政年份:
    2013
  • 资助金额:
    $ 59.04万
  • 项目类别:
Role of the innate immune system in acute kidney injury
先天免疫系统在急性肾损伤中的作用
  • 批准号:
    10655797
  • 财政年份:
    2013
  • 资助金额:
    $ 59.04万
  • 项目类别:

相似海外基金

SCH: Artificial Intelligence enabled multi-modal sensor platform for at-home health monitoring of patients
SCH:人工智能支持的多模式传感器平台,用于患者的家庭健康监测
  • 批准号:
    10816667
  • 财政年份:
    2023
  • 资助金额:
    $ 59.04万
  • 项目类别:
Cell-free DNA as a versatile analyte for the monitoring of sepsis
游离 DNA 作为监测脓毒症的多功能分析物
  • 批准号:
    10665402
  • 财政年份:
    2023
  • 资助金额:
    $ 59.04万
  • 项目类别:
Delineating the kidney brain axis in children with severe malaria (KID-BRAIN)
描绘严重疟疾儿童的肾脑轴(KID-BRAIN)
  • 批准号:
    10734142
  • 财政年份:
    2023
  • 资助金额:
    $ 59.04万
  • 项目类别:
Mentored research in the intersection of kidney and cardiovascular disease
肾脏和心血管疾病交叉领域的指导研究
  • 批准号:
    10795588
  • 财政年份:
    2023
  • 资助金额:
    $ 59.04万
  • 项目类别:
Mechanisms of subclinical renal injury in females following AKI: implications for adverse pregnancy outcomes
AKI 后女性亚临床肾损伤的机制:对不良妊娠结局的影响
  • 批准号:
    10568101
  • 财政年份:
    2023
  • 资助金额:
    $ 59.04万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了